| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, COO &CFO | Director +2 more
3 companies
Labrucherie Gil M is a SVP, COO &CFO at NEKTAR THERAPEUTICS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $22.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 3,177 | $19.32 | $61,379.64 | -4.8% | |
| May 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 3,179 | $19.55 | $62,149.45 | -4.6% | |
| Mar 3, 2017 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sale+OE | 200,000 | $15.16 | $3,031,949.64 | -49.0% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 2,359 | $13.14 | $30,997.26 | -3.3% | |
| Nov 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 1,654 | $13.96 | $23,089.84 | -3.1% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 3,305 | $17.56 | $58,035.80 | -5.9% | |
| May 17, 2016 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 836 | $13.58 | $11,352.88 | -9.5% | |
| Feb 17, 2016 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 827 | $11.92 | $9,857.84 | -11.2% | |
| Feb 10, 2016 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 11,666 | $11.49 | $134,042.34 | -69.0% | |
| Jan 19, 2016 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 11,667 | $14.12 | $164,738.04 | -69.0% |